Details

NameSymbolSector
INDO US BIOTECH LIMITEDINDOUSOther Agricultural Products
Open
138.95
High
138.95
Low
132.21
Close
133.15
Volume
12596
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

1

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Indo Us Biotech is  
Opening Marubozu
Estimated Stoploss of Indo Us Biotech is ₹  
138.95
Indo Us Biotech has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Indo Us Biotech has chances of  
Continuationℹ
 of the current trend. 

Trend

Indo Us Biotech is in  
Sideways trendℹ
. 
Price of Indo Us Biotech is  
Downℹ
 by  

10.79

%. 
Target
Buy @ 

125.81

Sell @ 

186.15

Current @ 

133.15

Volume

The trade volumes of Indo Us Biotech have become  
Deficientℹ
The volume trend for Indo Us Biotech is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Indo Us Biotech is  

Down

 by  

69.44

% 

Valuation

The current market price of Indo Us Biotech is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 97cr and total assets worth ₹ 97cr, the balance sheet of Indo Us Biotech is:  
Balancedℹ
. 
Cashflow
Indo Us Biotech has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 3cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

50% i.e. ₹ 1cr spent in operatingℹ
0% in investingℹ
50% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Indo Us Biotech has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

44.44% i.e. ₹ 4cr spent in operatingℹ
44.44% i.e. ₹ 4cr earned in investingℹ
11.11% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Income
The income of Indo Us Biotech is  

₹ 30cr

 and  

Profit

 is :  

₹ 4cr

(*Jun 2025)

Indo Us Biotech Profit is up by:  

33.33

% and Income is Down by:  

9.09

% 

(*Jun 2025)

The income of Indo Us Biotech is  

₹ 33cr

 and  

Profit

 is :  

₹ 3cr

(*Mar 2025)

Indo Us Biotech Profit is down by:  

40

% and Income is Up by:  

43.48

% 

(*Mar 2025)

The income of Indo Us Biotech is  

₹ 23cr

 and  

Profit

 is :  

₹ 5cr

(*Dec 2024)

Indo Us Biotech Profit is up by:  

25

% and Income is Up by:  

4.55

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.